image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Secondary Recommendation

BTG - Blockbuster hopes for new varicose vein treatment

July 2008

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BGC
  • Price:
  • 159p
BTG (FT sector: Pharmaceuticals & Biotech) was originally set up by the Government sixty years ago to capture the financial benefits of the UK’s new scientific discoveries, with the aim of developing and commercialising all intellectual property belonging to early stage drugs and technologies that had been funded by the taxpayer. By the time it floated in 1995, its remit had broadened into acquiring early stage technologies from UK universities and industry and the result is that it now receives a nice pool of royalty income worth £25m a year from a battery of patents, which are zealously policed by a team of lawyers.It sounds like a relatively easy life and indeed last year it made nearly £9m after tax, with its establish ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

BTG (December 2003)
BTG - Varisolve may float next year (October 2003)
BTG - Likely beneficiary when IPO window re-opens (September 2003)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe

SUBSCRIBE NOW